Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Monte Rosa Therapeutics (Nasdaq: GLUE) announced that its management will participate in two September 2026 investor events: a fireside chat at the Wells Fargo 21st Annual Healthcare Conference in Boston on September 10, 2026 at 12:45 p.m. ET, and the Morgan Stanley 24th Annual Global Healthcare Conference in New York on September 14, 2026.

A live webcast of the Wells Fargo fireside chat and a 30-day archive will be available in the “Events & Presentations” section of Monte Rosa’s investor relations website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management will participate in the following investor conferences:

• Wells Fargo 21st Annual Healthcare Conference (Boston, MA) – Markus Warmuth, M.D., Chief Executive Officer, to participate in a fireside chat, September 10, 2026, at 12:45 p.m. ET
• Morgan Stanley 24th Annual Global Healthcare Conference (New York, NY) – September 14, 2026
  
  

A webcast of the fireside chat will be accessible via the “Events & Presentations” section of Monte Rosa’s website at ir.monterosatx.com, and archived versions will be made available for 30 days following the presentations.

About Monte Rosa
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases. MGDs are small molecule protein degraders that have the potential to treat many diseases that other modalities, including other degraders, cannot. Monte Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology, and proteomics to rationally design MGDs with unprecedented selectivity. Monte Rosa has developed the industry’s leading pipeline of first-in-class and only-in-class MGDs, spanning autoimmune and inflammatory diseases, oncology, and beyond, with three programs in the clinic. Monte Rosa has ongoing collaborations with leading pharmaceutical companies in the areas of immunology, oncology and neurology. For more information, visit www.monterosatx.com.

Investors
Andrew Funderburk
ir@monterosatx.com

Media
Cory Tromblee, Scient PR
media@monterosatx.com

FAQ

When will Monte Rosa Therapeutics (GLUE) present at the Wells Fargo 21st Annual Healthcare Conference?

Monte Rosa will participate in a fireside chat on September 10, 2026 at 12:45 p.m. ET. According to the company, this session is part of the Wells Fargo 21st Annual Healthcare Conference in Boston, providing investors access to management’s latest strategic and pipeline updates.

Is there a webcast for Monte Rosa Therapeutics’ Wells Fargo 2026 conference fireside chat?

Yes, Monte Rosa will provide a live webcast of the fireside chat on its investor website. According to the company, the webcast will be available in the “Events & Presentations” section and archived for 30 days after the presentation.

What investor conferences will Monte Rosa Therapeutics (NASDAQ: GLUE) attend in September 2026?

Monte Rosa plans to attend the Wells Fargo 21st Annual Healthcare Conference and the Morgan Stanley 24th Annual Global Healthcare Conference. According to the company, both events occur in September 2026 in Boston and New York, respectively, featuring participation from senior management.

Who from Monte Rosa Therapeutics will speak at the Wells Fargo 21st Annual Healthcare Conference 2026?

Chief Executive Officer Markus Warmuth, M.D., will participate in a fireside chat on September 10, 2026. According to Monte Rosa, his appearance at the Wells Fargo 21st Annual Healthcare Conference offers investors direct insight into the company’s molecular glue degrader programs and strategy.

How can investors access Monte Rosa Therapeutics’ GLUE conference presentations and replays?

Investors can access the Wells Fargo fireside chat via webcast in the “Events & Presentations” section of Monte Rosa’s IR site. According to the company, archived versions will remain available online for 30 days following the presentation for later viewing.